Supernus Pharmaceuticals Long Term Debt Current 2011-2026 | SUPN

Annual Long Term Debt Current Supernus Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10.6 M	6.89 M	8.33 M	6.79 M	6.48 M	3.76 M	2.82 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.6 M	2.82 M	6.53 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Aquestive Therapeutics AQST	631 K	$ 4.16	1.46 %	$ 445 M	USA
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	675 K	$ 9.77	1.82 %	$ 632 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
BioNTech SE BNTX	45 M	$ 98.14	-5.13 %	$ 27.2 B	Germany
ACADIA Pharmaceuticals ACAD	9.96 M	$ 22.15	-1.36 %	$ 3.67 B	USA
Athira Pharma ATHA	465 K	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	382 M	-	-	$ 96.9 B	Britain
Cerus Corporation CERS	2.9 M	$ 2.79	37.44 %	$ 532 M	USA
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	3.29 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	1.37 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	7 K	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	2.81 M	-	-	$ 3.74 B	USA
Caladrius Biosciences CLBS	137 K	-	-16.75 %	$ 25.8 M	USA
Cardiff Oncology CRDF	730 K	$ 1.72	-0.87 %	$ 115 M	USA
Aeterna Zentaris AEZS	215 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	208 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	3.5 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Dynavax Technologies Corporation DVAX	4.18 M	-	-	$ 2.02 B	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	43 K	$ 2.93	-8.15 %	$ 4.82 M	Israel
Eiger BioPharmaceuticals EIGR	84 K	-	-9.21 %	$ 2.55 M	USA
Editas Medicine EDIT	6.03 M	$ 2.9	-3.48 %	$ 257 M	USA
Eloxx Pharmaceuticals ELOX	712 K	-	-5.68 %	$ 8.28 M	USA
Edesa Biotech EDSA	19.9 K	$ 17.81	-2.57 %	$ 56.9 M	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	429 K	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA